Check-Cap Ltd. (NASDAQ:CHEK) Short Interest Update

Check-Cap Ltd. (NASDAQ:CHEK) saw a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 152,800 shares, a decrease of 36.9% from the February 28th total of 242,000 shares. Based on an average daily trading volume, of 1,360,000 shares, the days-to-cover ratio is presently 0.1 days. Currently, 3.5% of the company’s shares are short sold.

Check-Cap Price Performance

Shares of Check-Cap stock traded down $0.05 during trading on Friday, hitting $0.79. The company’s stock had a trading volume of 15,652 shares, compared to its average volume of 366,541. The stock has a market cap of $4.62 million, a price-to-earnings ratio of -0.26 and a beta of 0.19. Check-Cap has a 52 week low of $0.56 and a 52 week high of $3.10. The stock has a 50-day moving average price of $0.90 and a two-hundred day moving average price of $1.10.

Analyst Upgrades and Downgrades

Separately, StockNews.com began coverage on shares of Check-Cap in a research report on Tuesday. They set a “sell” rating on the stock.

Check-Cap Company Profile

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.